Tobacco Product Use and COVID-19: An Overview of the Science and Public Health Implications
Deputy Director for Research Translation, Office on Smoking and Health, Centers for Disease Control and Prevention
Dr. King provides scientific leadership and technical expertise related to multiple aspects of tobacco prevention and control. He joined the CDC and OSH in 2010 as an Epidemic Intelligence Service Officer, before which he worked as a Research Affiliate in the Division of Cancer Prevention and Population Sciences at Roswell Park Cancer Institute in Buffalo, New York. During his time at Roswell Park, his research focus was tobacco prevention and control. Dr. King has worked for 15 years to provide sound scientific evidence to guide tobacco control policy and to communicate this information to decision makers, the media, and the general public. He has authored or coauthored over 175 peer-reviewed scientific articles about tobacco prevention and control, was senior editor of the 2016 and 2020 Surgeon General’s Report, lead author of CDC’s “Best Practices for Comprehensive Tobacco Control Programs,” and Senior Official for CDC’s 2019 Emergency Operations Center activation for E-cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI). He holds a PhD and MPH in epidemiology from the State University of New York at Buffalo.
Tobacco product use is the leading cause of disease, disability, and death in the United States. The risks of tobacco product use have been compounded by the COVID-19 pandemic, with emerging data showing that current and former cigarette smokers are at increased risk of more severe illness from COVID-19. In this webinar, participants will gain an understanding of the state of the science with regard to COVID-19 outcomes and tobacco product use, including cigarette smoking and e-cigarette use. The speaker will also provide participants with information about evidence-based strategies to prevent and reduce tobacco product use, including resources for healthcare providers and the general public.
At the end of the webinar, you will be able to:
- Describe the adverse health effects of tobacco product use in the United States, as well as disparities in use across population groups.
- Discuss the state of the science with regard to COVID-19 outcomes and tobacco product use, including cigarette smoking and e-cigarette use.
- Explain clinical and public health approaches to prevent and reduce tobacco product use, including during the COVID-19 pandemic.
The CME/CEU registration site is open for this recorded activity. Scroll down and click on the "Get Credit" button to begin.
Certificates of Attendance
Click here to generate a certificate of attendance for participating on this webinar.
The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
UCSF designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the webinar activity.
Advance Practice Registered Nurses and Registered Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 CreditTM issued by organizations accredited by the ACCME.
Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 CreditTM are acceptable for continuing medical education requirements for recertification.
California Pharmacists: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA category 1 CreditTM. If you are a pharmacist in another state, you should check with your state board for approval of this credit.
California Psychologists: The California Board of Psychology recognizes and accepts for continuing education credit courses that are provided by entities approved by the Accreditation Council for Continuing Medical Education (ACCME). AMA PRA Category 1 CreditTM is acceptable to meeting the CE requirements for the California Board of Psychology. Providers in other states should check with their state boards for acceptance of CME credit.
California Behavioral Science Professionals: University of California, San Francisco School of Medicine (UCSF) is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for behavioral health providers. UCSF maintains responsibility for this program/course and its content.
Course meets the qualifications for 1.0 hour of continuing education credit for LMFTs, LCSWs, LPCCs, and/or LEPs as required by the California Board of Behavioral Sciences. Provider # 64239.
ACCREDITATION FOR CALIFORNIA ADDICTION COUNSELORS
The UCSF office of continuing medical education is accredited by the California Consortium of Addiction Programs and Professionals (CCAPP), to provide continuing education credit for California addiction counselors. UCSF designates this live, virtual activity, for a maximum of 1.0 CCAPP credit. Addiction counselors should claim only the credit commensurate with the extent of their participation in the activity. Provider number: 7-20-322-0722.
This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.
The following speakers, moderators and planning committee members have disclosed they have no financial interest/arrangement or affiliation with any commercial companies who have provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity:
Anita Browning, Christine Cheng, Brian Clark, Brian A. King, PhD, MPH, Jennifer Matekuare, Ma Krisanta Pamatmat, MPH, Jessica Safier, MA, Catherine Saucedo, Steven A. Schroeder, MD, and Aria Yow, MA.